021-33882916
Company ProfileCompany History Company News Staff Corner

About Fresh Bioscience


Fresh Bioscience Ltd, founded in March 2017, specializing in chromatographic separation technologies. Driven by research and innovation, it has rapidly grown into a scientific company.

We deeply understand the critical role of chromatographic analysis in both scientific research and industrial product quality control. By providing comprehensive solutions that include high-performance column packing equipment, premium chromatographic media, and essential consumables, we empower innovative laboratories to develop efficient analytical methods. Our commercial LC columns—covering a wide range of separation modes such as reversed-phase, hydrophilic interaction, and ion exchange—offer exceptional performance, perfect reproducibility, and long lifespan, enabling scientists and engineers to obtain reliable results quickly across nano-flow to prep-flow LC systems.

The core team members each have more than a decade of experience working with well-known life science company. We continue to explore the frontiers of chromatographic science and look forward to partnering with you to shape an intelligent, data-driven future.

Company History


  • 1984

    Exmere founded

  • 1985

    Development of a Novel Aqueous Process for spherical Silica Spheres Independent Control of Pore Volume, Pore Diameter and Surface Area

    Exsil Range:
    ·Pore Size: 60-1000Å
    ·Particle Size: 1.5-50 µm
    ·Pore Volume: 0.5-1.3 ml/g
    ·Surface Area: <500 m2/g
    ·Bonding: Extensive Range

  • 1988

    3 Micron Wide Pore Silica Gel

  • 1990

    Exsil 80 Alternative to Spherisorb

  • 1993

    Introduction of first commercially available sub2 micron Silica Gel worldwide (Exsil 100 ODS, 1.5 µm)

  • 1995

    Platinum Silica and EPS Bonding A unique diametric opposite to current RP18

  • 1999

    Avanti / Avanti BDS Alternative to Hypersil

  • 2003

    Exsil Pure High purity silica, RP18 and C18MS
    GFC3000 Alternative to TSK G3000SW for protein SEC

  • 2004

    Exsil Polar P for Drugs in Serum

  • 2005

    Acquired by GRACE Alltech

  • 2016

    Split off from GRACE // Stand alone company Exmere Ltd. and Development of non-porous 1.5 µm Silica Phases in the same year

  • 2017

    Release of coated and immobilized Polysaccharide Phases as alternative to Daicel Chiralpak / Chiracel

  • 2018

    Development of 500Å pore size High Purity Silica gel for Rapid Analysis of Proteins and Peptides

  • 2019

    Developed and commercialized 1.0 um Silica gel with column efficiency exceeding 500,000 N/m

  • 2020

    Developed an ultra-high purity SenSil UHPLC columns

  • 2021

    Development of Empowered CapaSil HPLC columns

  • 2022

    Development of Omics sample preparation kits, named as PreciEx